Drug intelligence / Profile preview

ramipril

Development stage
Approved
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. It is also prescribed to reduce the risk of heart attack, stroke, and cardiovascular death in patients at high risk for these events. Ramipril acts as a prodrug that is converted in the body to its active form, ramiprilat. The primary mechanism of action involves inhibition of ACE, which prevents the conversion of angiotensin I to angiotensin II—a potent vasoconstrictor—thereby relaxing blood vessels and lowering blood pressure. Additionally, by inhibiting ACE (also known as kininase II), ramipril increases bradykinin levels leading to further vasodilation[1][2][3][4][5][6].

Brand names
AltaceTriapin
Other names
Ramiprin
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on ramipril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ramipril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call